597
Participants
Start Date
August 2, 2017
Primary Completion Date
July 16, 2018
Study Completion Date
January 12, 2019
Insulin aspart
SAR341402 100 units per milliliters (U/mL) (dose range of 1 unit to 80 units) self-administered by SC injection, immediately (within 5-10 minutes) before meal intake. Dose adjusted to achieve a 2-hour postprandial plasma glucose (PPG \<10 millimoles/liter \[mmol/L\] \[\<180 milligram/deciliter {mg/dL}\]) while avoiding hypoglycemia.
NovoLog/NovoRapid
NovoLog/NovoRapid 100 U/mL (dose range of 1 unit to 60 units) self-administered by SC injection, immediately (within 5-10 minutes) before meal intake. Dose adjusted to achieve a 2-hour postprandial plasma glucose (PPG \<10 mmol/L \[\<180 mg/dL\]) while avoiding hypoglycemia.
Insulin glargine (HOE901)
Insulin glargine 100 U/mL injected QD subcutaneously consistent with the local label. Doses adjusted to achieve glycemic target for fasting, preprandial plasma glucose between 4.4 to 7.2 mmol/L (80 to 130 mg/dL) without hypoglycemia.
Investigational Site Number 3480011, Budapest
Investigational Site Number 3480008, Budapest
Investigational Site Number 3480001, Budapest
Investigational Site Number 3480005, Budapest
Investigational Site Number 3480004, Budapest
Investigational Site Number 3480009, Szentendre
Investigational Site Number 3480007, Debrecen
Investigational Site Number 3480010, Nyíregyháza
Investigational Site Number 3480012, Balatonfüred
Investigational Site Number 3480003, Nagykanizsa
Investigational Site Number 8400028, New York
Investigational Site Number 2760001, Berlin
Investigational Site Number 2760005, Oldenburg in Holstein
Investigational Site Number 8400039, Bridgeport
Investigational Site Number 8400010, Wilmington
Investigational Site Number 2460004, Pori
Investigational Site Number 8400025, Morehead City
Investigational Site Number 8400032, Roswell
Investigational Site Number 8400007, Atlanta
Investigational Site Number 8400022, Columbus
Investigational Site Number 8400031, New Port Richey
Investigational Site Number 8400027, Ocoee
Investigational Site Number 8400033, Chattanooga
Investigational Site Number 2460006, Jyväskylä
Investigational Site Number 2760006, Essen
Investigational Site Number 8400005, Des Moines
Investigational Site Number 8400023, Fargo
Investigational Site Number 8400038, Arlington Heights
Investigational Site Number 2460003, Seinäjoki
Investigational Site Number 8400003, Omaha
Investigational Site Number 2760004, Heidelberg
Investigational Site Number 8400041, Metairie
Investigational Site Number 2460002, Kuopio
Investigational Site Number 8400040, Little Rock
Investigational Site Number 8400016, Mesquite
Investigational Site Number 8400009, Dallas
Investigational Site Number 8400035, Dallas
Investigational Site Number 8400021, Dallas
Investigational Site Number 8400017, Houston
Investigational Site Number 8400001, Houston
Investigational Site Number 8400020, Houston
Investigational Site Number 8400044, Austin
Investigational Site Number 8400037, Aurora
Investigational Site Number 8400018, Englewood
Investigational Site Number 8400034, Salt Lake City
Investigational Site Number 8400024, Henderson
Investigational Site Number 8400043, Los Angeles
Investigational Site Number 8400036, Pomona
Investigational Site Number 8400002, Escondido
Investigational Site Number 8400014, La Jolla
Investigational Site Number 8400013, Ventura
Investigational Site Number 8400011, Santa Barbara
Investigational Site Number 8400030, Fresno
Investigational Site Number 8400012, Concord
Investigational Site Number 8400004, Greenbrae
Investigational Site Number 8400029, Bend
Investigational Site Number 8400008, Renton
Investigational Site Number 6430001, Saint Petersburg
Investigational Site Number 6430003, Saratov
Investigational Site Number 6430002, Samara
Investigational Site Number 6430004, Tomsk
Investigational Site Number 8400015, Rockville
Investigational Site Number 8400042, Waltham
Investigational Site Number 8400019, Flint
Investigational Site Number 2760002, Pirna
Investigational Site Number 3920009, Fukuyama-Shi
Investigational Site Number 3920008, Higashiosaka-Shi
Investigational Site Number 3920007, Kashiwara-Shi
Investigational Site Number 3920001, Koriyama-Shi
Investigational Site Number 3920005, Kumamoto
Investigational Site Number 3920003, Mito
Investigational Site Number 3920010, Osaka
Investigational Site Number 3920002, Sagamihara-Shi
Investigational Site Number 3920004, Shinjuku-Ku
Investigational Site Number 3920006, Ushiku-Shi
Investigational Site Number 6160004, Bialystok
Investigational Site Number 6160003, Krakow
Investigational Site Number 6160005, Krakow
Investigational Site Number 6160007, Lublin
Investigational Site Number 6160006, Nowy Sącz
Investigational Site Number 6160001, Poznan
Investigational Site Number 6160002, Warsaw
Lead Sponsor
Sanofi
INDUSTRY